Commonwealth Equity Services’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PVCT
Commonwealth Equity Services's PVCT Position: Q4 2016 in Review
Commonwealth Equity Services sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 44,720 shares — an estimated $4K sold.
Commonwealth Equity Services first reported a position in PVCT in Q2 2014 and held it in 10 quarters. The position peaked at $83K in Q3 2014. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.
- Commonwealth Equity Services reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
- Commonwealth Equity Services sold 44,720 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016, an estimated $4K.
- Commonwealth Equity Services first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2014 and held it in 10 quarters.
- Commonwealth Equity Services's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $83K in Q3 2014.
- 8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.
Based on Commonwealth Equity Services's 13F filing for Q4 2016, filed 1 Feb 2017.